Company / Free Cash Flow
Oncology Institute, Inc. Free Cash Flow History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$30.3M
FY2025
5-year range
-$67.3M / -$686.0K
FY2021-FY2025
Trend
+25.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -$67M to -$30M over the past 2 years.
Based on SEC 10-K filings.
-$30M in FY2025.
Improved from -$67M to -$30M over the past 2 years.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, free cash flow increased 25.8% year-over-year.
- Peak free cash flow was recorded in FY2021.
- Lowest free cash flow in the period was in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$30.3M | +25.8% |
| FY2024 | -$40.9M | +39.2% |
| FY2023 | -$67.3M | -89.4% |
| FY2022 | -$35.5M | -5078.9% |
| FY2021 | -$686.0K | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026